Renaissance Capital
MDLN icon

Renaissance Capital’s Medline Inc MDLN Stock Holding History

Renaissance Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.88M Sell
169,355
-59,473
-26% -$2.18M 4.06% 7
2026
Q2 		$9.02M Buy
228,828
+78,524
+52% +$3.16M 4.98% 6
2026
Q1 		$6.68M Buy
+150,304
New +$6.64M 4.84% 6

Other funds holding MDLN

Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Bank Pictet & Cie (Europe)
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return
Cullen/Frost Bankers
Cullen/Frost Bankers San Antonio, Texas $10.2B AUM 22.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Renaissance Capital's MDLN Position: Q3 2026 in Review

Renaissance Capital reduced its Medline Inc (MDLN) stake by 26% in Q3 2026, selling an estimated $2.18M and leaving 169,355 shares worth $5.88M. The position accounts for 4.06% of the portfolio, ranked #7.

Renaissance Capital first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.02M in Q2 2026. 111 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Renaissance Capital held 169,355 shares of Medline Inc worth $5.88M as of Q3 2026.
  • Renaissance Capital sold 59,473 Medline Inc shares in Q3 2026, an estimated $2.18M.
  • Medline Inc made up 4.06% of Renaissance Capital's portfolio in Q3 2026, its #7 holding.
  • Renaissance Capital first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
  • Renaissance Capital's Medline Inc position peaked at $9.02M in Q2 2026.
  • 111 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Renaissance Capital's 13F filing for Q3 2026, filed 23 Oct 2026.